Lucà , F.; Giubilato, S.; Di Fusco, S.A.; Piccioni, L.; Rao, C.M.; Iorio, A.; Cipolletta, L.; D’Elia, E.; Gelsomino, S.; Rossini, R.;
et al. Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account. J. Clin. Med. 2021, 10, 3212.
https://doi.org/10.3390/jcm10153212
AMA Style
Lucà F, Giubilato S, Di Fusco SA, Piccioni L, Rao CM, Iorio A, Cipolletta L, D’Elia E, Gelsomino S, Rossini R,
et al. Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account. Journal of Clinical Medicine. 2021; 10(15):3212.
https://doi.org/10.3390/jcm10153212
Chicago/Turabian Style
Lucà , Fabiana, Simona Giubilato, Stefania Angela Di Fusco, Laura Piccioni, Carmelo Massimiliano Rao, Annamaria Iorio, Laura Cipolletta, Emilia D’Elia, Sandro Gelsomino, Roberta Rossini,
and et al. 2021. "Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account" Journal of Clinical Medicine 10, no. 15: 3212.
https://doi.org/10.3390/jcm10153212
APA Style
Lucà , F., Giubilato, S., Di Fusco, S. A., Piccioni, L., Rao, C. M., Iorio, A., Cipolletta, L., D’Elia, E., Gelsomino, S., Rossini, R., Colivicchi, F., & Gulizia, M. M.
(2021). Anticoagulation in Atrial Fibrillation Cardioversion: What Is Crucial to Take into Account. Journal of Clinical Medicine, 10(15), 3212.
https://doi.org/10.3390/jcm10153212